Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer

Grunfeld, Eva; Julian, Jim A.; Pond, Gregory R.; Maunsell, Elizabeth; Coyle, Doug; Folkes, Amy; Joy, Anil A.; Provencher, Louise; Rayson, Daniel; Rheaume, D.; Porter, Geoffrey A.; Paszat, Lawrence; Pritchard, Kathleen I.; Robidoux, André; Smith, Sally; Sussman, Jonathan; Dent, Susan; Sisler, Jeffrey; Wiernikowski, Jennifer; Levine, Mark

doi:10.1200/jco.2011.36.8373

Cited by 293 publications

(305 citation statements)

References 27 publications

Supporting

Mentioning

293

Contrasting

Unclassified

Order By: Relevance

“…The ability to give proper feedback with respect to endocrine therapyrelated issues may be suboptimal among nonspecialists and hence decrease adherence. However, a Canadian study reported that primary health care doctors can follow-up patients with breast cancer without adversely affecting outcome (49). As per recent guideline changes in southern Sweden, patients no longer routinely follow-up with their breast cancer physician beyond the first year postsurgery.…”

Section: Discussionmentioning

confidence: 99%

Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort

Markkula

Hietala

Henningson

et al. 2012

Cancer Prevention Research

View full text Add to dashboard Cite

Nonadherence to adjuvant endocrine breast cancer treatment adversely affects disease-free and overall survival. Clinical predictors of nonadherence may allow for specific interventions to reduce nonadherence and improve survival. The aim was to investigate whether clinical characteristics predict nonadherence. Clinical characteristics and information on adherence were obtained from 417 patients with breast cancer in a population-based prospective cohort from southern Sweden using patient charts, pathology reports, and questionnaires filled out at the 1-and 2-year follow-up visits. At the 1-and 2-year follow-up visits, 36 (8.6%) and 33 (9.7%) patients were nonadherent, respectively. Thirteen of the nonadherent patients declined treatment and were never prescribed endocrine treatment. A body mass index (BMI) < 25 kg/m 2 , preoperative current smoking, and drinking alcohol less often than twice a month predicted nonadherence at the 1-year [relative risk (RR), 5.24; 95% confidence interval (CI), 2.75-9.97] and the 2-year visits (RR, 4.07; 95% CI, 2.11-7.84) in patients with at least two of these clinical characteristics. When low histologic grade (I) was added to the model, having at least two of these four clinical characteristics predicted nonadherence at the 1-year (RR, 4.94; 95% CI, 2.46-10.00) and the 2-year visits (RR, 4.74; 95% CI, 2.28-9.87), the two profiles had a sensitivity ranging from 60.6% to 72.7%, whereas the specificity ranged from 68.0% to 78.4%. Nonadherence at the 1-year visit was associated with an increased risk for early breast cancer events (HR, 2.97; 95% CI, 1.08-8.15), adjusted for age and tumor characteristics. In conclusion, two clinical profiles predicted early nonadherence and may allow for targeted interventions to increase adherence if validated in an independent cohort. Cancer Prev Res; 5(5); 735-45. Ó2012 AACR.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort

Markkula

Hietala

Henningson

et al. 2012

Cancer Prevention Research

View full text Add to dashboard Cite

show abstract

“…Some of the barriers are insufficient consensus about the required content of the scp and insufficient staff time to prepare and deliver the scp 43 . Grunfeld et al 49 reported that scps are not seen as any better or different from the standard discharge or transfer to the community. However, that particular clinical trial was neither a longitudinal study nor an exploration of cultural or social factors that might be important to take into consideration, especially the ways in which people experience health and illness and their expectations for health care delivery.…”

Section: Recommendations For Cancer Care Providersmentioning

confidence: 99%

Breast Cancer Survivorship and South Asian Women: Understanding about the Follow-Up Care Plan and Perspectives and Preferences for Information Post Treatment

et al. 2013

View full text Add to dashboard Cite

be experienced in common with bcss of other ethnic backgrounds, but the present study also suggests the presence of unique cultural nuances such as spiritual and language-specific support resource needs. The results provide direction for designing key content and format of scps, and information about elements of care that can be customized to individual patient needs. KEY WORDSSouth Asian women, breast cancer survivors, survivorship care, social and cultural aspects of cancer, psychosocial and physical functioning, life stage

show abstract

“…Subsequently, the American College of Surgeons' Commission on Cancer (CoC) called for implementation of SCPs by January 2015 in all accredited programs [2]. While the practice community strives to comply with the CoC directive and impending deadline, the scientific community is scrambling to catch up: evidence regarding the impact of survivorship care plans and care planning interventions remains scant, largely developmental, and somewhat controversial, as outlined in a series of earlier commentaries and articles [3][4][5][6][7][8][9][10][11][12][13][14][15][16]. The challenges to the development of science in this area have included the absence of a conceptual framework guiding empirical efforts and a lack of consensus and recommendations about the appropriate constructs and process and outcome measures to use in assessing survivorship care planning.…”

mentioning

confidence: 99%

It takes a (virtual) village: crowdsourcing measurement consensus to advance survivorship care planning

Parry

Beckjord

Moser³

et al. 2014

Behav. Med. Pract. Policy Res.

View full text Add to dashboard Cite

We report results from the use of an innovative tool (the Grid-Enabled Measures (GEM) database) to drive consensus on the use of measures evaluating the efficacy and implementation of survivorship care plans. The goal of this initiative was to increase the use of publicly available shared measures to enable comparability across studies. Between February and August 2012, research and practice communities populated the GEM platform with constructs and measures relevant to survivorship care planning, rated the measures, and provided qualitative feedback on the quality of the measures. Fiftyone constructs and 124 measures were entered into the GEM-Care Planning workspace by participants. The greatest number of measures appeared in the domains of Health and Psychosocial Outcomes, Health Behaviors, and Coordination of Care/Transitional Care. Using technology-mediated social participation, GEM presents a novel approach to how we measure and improve the quality of survivorship care.

show abstract

Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer

Cited by 293 publications

References 27 publications

Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort

Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort

Breast Cancer Survivorship and South Asian Women: Understanding about the Follow-Up Care Plan and Perspectives and Preferences for Information Post Treatment

It takes a (virtual) village: crowdsourcing measurement consensus to advance survivorship care planning

Contact Info

Product

Resources

About